These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2332336)

  • 1. Edinburgh's community drug problem service--a pilot evaluation of methadone substitution.
    Chalmers JW
    Health Bull (Edinb); 1990 Mar; 48(2):62-72. PubMed ID: 2332336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot survey of client opinion of the Lothian Community Drug Problem Service: likes, dislikes, efficacy and improvements.
    Kay RW; Peters AD
    Health Bull (Edinb); 1992 Jan; 50(1):32-8. PubMed ID: 1319417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Schilling RF; el-Bassel N; Hadden B; Gilbert L
    Soc Work; 1995 Jan; 40(1):91-101. PubMed ID: 7863377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edinburgh drug users: are they injecting and sharing less?
    Peters AD; Reid MM; Griffin SG
    AIDS; 1994 Apr; 8(4):521-8. PubMed ID: 8011257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New needles for old.
    Cameron J
    Nursing (Lond); 1991 Jul 11-24; 4(38):15-7. PubMed ID: 1876301
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of an AIDS prevention education program for health service providers working with i.v. drug users.
    Nelson FL; Kabacy M
    J Subst Abuse; 1989; 1(4):467-70. PubMed ID: 2485292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial risk factors for HIV transmission in male drug abusers.
    Brook JS; Brook DW; Whiteman M; Roberto J; Masci JR; De Catalogne J; Amundsen F
    Genet Soc Gen Psychol Monogr; 1993 Aug; 119(3):369-87. PubMed ID: 8243990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous heroin use: its association with HIV infection in patients in methadone treatment.
    Chu A; Brown LS; Banks S; Nemoto T; Primm BJ
    NIDA Res Monogr; 1989; 95():447-8. PubMed ID: 2641025
    [No Abstract]   [Full Text] [Related]  

  • 13. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of primary care services by drug users attending a HIV prevention unit.
    Bury G; O'Kelly F; Pomeroy L
    Ir Med J; 1993 Mar; 86(2):53-5. PubMed ID: 8473136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical and psychosocial effects of methadone substitution in HIV infected substance-dependent patients].
    Walger P; Baumgart P; Wilke G; Kupfer U; von Eiff M; Dorst KG
    Psychother Psychosom Med Psychol; 1989 Nov; 39(11):381-9. PubMed ID: 2587688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.